q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

August 2023 Medicare Drug List Updates: Sixty-three (63) medications added to the 2023 Medicare Part D Drug plan formularies.

Category: Monthly Formulary changes
Published: Sep, 06 2023 02:09:09
< Previous
Next >
The August 2023 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The August formulary updates include the addition of 94 new National Drug Codes (NDCs), representing 63 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the August 2023 Formulary updates include ten (10) newly-introduced brand-name drugs

The August drug data updates include thirty-nine (39) new brand-name drugs, ten (10) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • ABILIFY ASIMTUFII®,
  • AUGMENTIN ES®,
  • CUVRIOR®,
  • FILSPARI®,
  • REZVOGLAR®,
  • ROTAVIRUS VACCINE®,
  • UZEDY®,
  • VOWST®,
  • XELSTRYM®, and
  • ZOKINVY®.

The August 2023 Formulary updates include five (5) newly-added generic drugs

The August Medicare Part D drug data also includes twenty-four (24) new generic medications, five (5) of which are newly-introduced generic drugs.  These new generic drugs include:
  • BASAGLAR [SEMGLEE®],
  • KCL-D5W-NACL IV SOLN,
  • TRAMADOL HCL [QDOLO®],
  • TRIAZOLAM [HALCION®], and
  • VANCOMYCIN [FIRVANQ®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of August 2023 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 94 new August 2023 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 10
New Delivery Form and Strength 3
New Drug 23
New Drug and Strength 31
New Drug, Manufacturer and Strength 2
New Manufacturer and Delivery Form 4
New Manufacturer and Strength 9
New Manufacturer, Strength and Delivery Form 2
New Strength 10
Grand Total 94

The following chart details the 94 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
59148010280ABILIFY ASIMTUFII 720 MG/2.4ML SUSER SYRINGE33188New Drug and Strength
59148011480ABILIFY ASIMTUFII 960 MG/3.2ML SUSER SYRINGE33188New Drug and Strength
00078073610ALOMIDE 0.1% EYE DROPS283New Drug
55513041301AMJEVITA(CF) 10MG/0.2ML SYRINGE742New Strength
28595024035AUGMENTIN 125-31.25 MG/5 ML ORAL SUSPENSION1465New Drug and Strength
81964000354AUGMENTIN ES-600 ORAL SUSPENSION05New Drug and Strength
68546047156AUSTEDO XR 12 MG TABLET ER 24H15254New Strength
68546047256AUSTEDO XR 24 MG TABLET ER 24H15254New Strength
68546047056AUSTEDO XR 6 MG TABLET ER 24H15254New Strength
82584030703AZASITE 1% EYE DROPS3138New Drug
52536060012BACLOFEN 25 MG/5 ML ORAL SUSPENSION [FLEQSUVY]05New Drug
00002821405BASAGLAR TEMPO PEN 100 UNIT/ML INSULIN PEN[Semglee]426New Drug
82584000105BETIMOL 0.25% EYE DROPS447New Drug and Strength
82584000205BETIMOL 0.5% EYE DROPS447New Drug and Strength
49884015154BISMUTH-METRO-TETR 140-125-125 CAPSULE [Pylera]1297New Drug
45802062786BUDESONIDE 2 MG RECTAL FOAM/APPL [UCERIS Rectal]1113New Drug
74528006001BYLVAY 600 MCG PELLET DSP CP279New Strength
72888011801CEVIMELINE HCL 30 MG CAPSULE [Evoxac]20300New Drug
82584060401COSOPT PF EYE DROPS DROPERETTE02New Drug and Strength
82584060510COSOPT EYE DROPS12New Drug and Strength
81802000172CUVRIOR 300 MG TABLET319New Drug
00713088660DAPSONE 5% GEL [Aczone]428New Manufacturer and Strength
16729043445DAPTOMYCIN 350 MG VIAL [Cubicin RF]33257New Manufacturer and Strength
00009737611DEPO-PROVERA 150 MG/ML SYRINGE12New Drug
00078086225DUREZOL 0.05% EYE DROPS852New Drug
71288041181ENOXAPARIN 120 MG/0.8 ML SYRINGE [Lovenox]62391New Manufacturer and Strength
71288041183ENOXAPARIN 150 MG/ML SYRINGE [Lovenox]62391New Manufacturer and Strength
00548560100ENOXAPARIN 30 MG/0.3 ML SYRINGE [Lovenox]62391New Strength
71288041083ENOXAPARIN 40 MG/0.4 ML SYRINGE [Lovenox]62391New Manufacturer and Strength
71288041087ENOXAPARIN 80 MG/0.8 ML SYRINGE [Lovenox]62391New Manufacturer and Strength
68974020030FILSPARI 200 MG TABLET568New Drug and Strength
68974040030FILSPARI 400 MG TABLET568New Drug and Strength
54838052340FLUOXETINE 20 MG/5 ML SOLUTION [Prozac]62391New Manufacturer, Strength and Delivery Form
50742036630GEFITINIB 250 MG TABLET [Iressa]62389New Drug
00078096589GILENYA 0.25 MG CAPSULE20171New Strength
00002821305HUMALOG TEMPO PEN 100 UNIT/ML INSULN PEN2248New Manufacturer and Delivery Form
51167077001KALYDECO 13.4 MG GRANULES PACKET57376New Strength
65219014210KCL 10 MEQ/L-D5W-0.45% NACL IV SOLUTION55315New Drug and Strength
65219014410KCL 20 MEQ/L-D5W-0.45% NACL IV SOLUTION57328New Drug and Strength
65219011810KCL 20 MEQ/L-D5W-0.9% NACL IV SOLUTION33288New Drug and Strength
65219014610KCL 30 MEQ/L-D5W-0.45% NACL IV SOLUTION55316New Drug and Strength
65219014810KCL 40 MEQ/L-D5W-0.45% NACL IV SOLUTION55313New Drug and Strength
65219011910KCL 40 MEQ/L-D5W-0.9% NACL IV SOLUTION33285New Drug and Strength
55513050450LUMAKRAS 320 MG TABLET62391New Strength
00002823505LYUMJEV TEMPO PEN 100 UNIT/ML INSULIN PEN2137New Delivery Form
00078116147MEKINIST 0.05 MG/ML SOLUTION RECON62390New Delivery Form
70954022810METHSUXIMIDE 300 MG CAPSULE [Celontin]62387New Drug
51672137606NAFTIFINE HCL 2% GEL [Naftin]862New Delivery Form
00071201247NEURONTIN 250 MG/5 ML SOLUTION12New Delivery Form and Strength
70505022060NITISINONE 20 MG CAPSULE [Orfadin]55293New Manufacturer and Strength
00472199208NITROFURANTOIN 25 MG/5 ML ORAL SUSPENSION [Furadantin]1892New Drug
00074234030NORVIR 100 MG TABLET25New Delivery Form
66302036256ORENITRAM MONTH 2 TITRATION KIT ER DSPK8101New Delivery Form
66302036128ORENITRAM MONTH 1 TITRATION KIT ER DSPK8101New Delivery Form
66302036384ORENITRAM MONTH 3 TITRATION KIT ER DSPK8101New Delivery Form
55494058090OSPHENA 60 MG TABLET14147New Drug
62559032580PANDEL 0.1% CREAM (G)117New Drug
55111066430PARICALCITOL 2 MCG CAPSULE [Zemplar]62381New Manufacturer and Strength
00054044949POSACONAZOLE 200 MG/5 ML ORAL SUSPENSION [Noxafil]42335New Manufacturer, Strength and Delivery Form
52817011710PRIMIDONE 125 MG TABLET61332New Drug
00002898005REZVOGLAR 100 UNIT/ML INSULN KWIKPEN011New Drug
58160074002Rotavirus Vaccine, Live, Oral62385New Drug
00078115421TAFINLAR 10 MG TABLET FOR SUSPENSION62390New Delivery Form and Strength
00409656220TESTOSTERONE CYP 2,000 MG/10ML VIAL [Virilon]62386New Drug, Manufacturer and Strength
00574082001TESTOSTERONE CYP 200 MG/ML VIAL [Virilon]62385New Drug, Manufacturer and Strength
10370036811TOPIRAMATE ER 200 MG CAPSULE 24H [Trokendi XR]427New Manufacturer and Strength
52817061516TRAMADOL HCL 5 MG/ML SOLUTION [QDOLO]017New Drug
70710152101TRIAZOLAM 0.125 MG TABLET [Halcion]7114New Drug and Strength
70710128901TRIAZOLAM 0.25 MG TABLET [Halcion]4110New Drug and Strength
51167044601TRIKAFTA 100-50-75 MG/75MG GRANULES PACKET SQ24280New Delivery Form
51167044501TRIKAFTA 80-40-60MG/59.5MG GRANULES PACKET SQ24280New Delivery Form
65597040720TURALIO 125 MG CAPSULE62391New Strength
70114012001UDENYCA 6 MG/0.6 ML AUTO-INJECTOR16199New Delivery Form
51759052010UZEDY ER 100 MG/0.28 ML SYRINGE28166New Drug and Strength
51759063010UZEDY ER 125 MG/0.35 ML SYRINGE28166New Drug and Strength
51759074010UZEDY ER 150 MG/0.42 ML SYRINGE28166New Drug and Strength
51759085010UZEDY ER 200 MG/0.56 ML SYRINGE28166New Drug and Strength
51759096010UZEDY ER 250 MG/0.7 ML SYRINGE28166New Drug and Strength
51759030510UZEDY ER 50 MG/0.14 ML SYRINGE28166New Drug and Strength
51759041010UZEDY ER 75 MG/0.21 ML SYRINGE28166New Drug and Strength
52536010405VANCOMYCIN 25 MG/ML ORAL SOLUTION RECON [FIRVANQ]5153New Drug
65219019030VORICONAZOLE 200 MG VIAL [VFEND]62391New Manufacturer and Delivery Form
71881040012VOWST CAPSULE257New Drug
68968021503XELSTRYM 13.5 MG/9 HR PATCH03New Drug and Strength
68968022003XELSTRYM 18 MG/9 HR PATCH03New Drug and Strength
68968020503XELSTRYM 4.5 MG/9 HR PATCH03New Drug and Strength
68968021003XELSTRYM 9 MG/9 HR PATCH03New Drug and Strength
82584060930ZIOPTAN 0.0015% EYE DROP DROPERETTE145New Drug
73079005030ZOKINVY 50 MG CAPSULE34130New Drug and Strength
73079007530ZOKINVY 75 MG CAPSULE34130New Drug and Strength
60846238303ZOMIG 2.5 MG TABLET04New Manufacturer and Delivery Form
60846238404ZOMIG 5 MG TABLET04New Manufacturer and Delivery Form
00338963224ZOSYN 2.25 GM/50 ML GALAXY BAG FROZ.PIGGY1140New Drug
00009513604ZYVOX 100 MG/5 ML ORAL SUSPENSION13New Delivery Form and Strength




If your brand-name drug is no longer covered by your Medicare Part D plan, you can use the 30-day notice period (if notice is provided) to:
  • Ask your prescriber about trying the generic.

  • Check for an alternative formulary drug.

  • Ask your plan to cover a non-formulary drug. 
    You will need to work with your doctor or prescriber to explain why you are not able to use the generic medication or why no other formulary drug is acceptable.  If your formulary exception is denied, you have the right to appeal your plan’s decision.

  • Consider using a Special Enrollment Period and move to another Medicare plan that provides coverage of all your prescription and health needs.
Learn more in our article: How a mid-year formulary change can affect your Medicare Part D drug coverage.

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
April 2024, September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
April 2024, September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting your Medicare plan
Star Ratings & plan quality
Annual Medicare plan changes
Enrollment topics
Late Enrollment Penalty (LEP)
Your Formulary (Drug List)
Monthly Formulary changes
Your Medicare plan coverage
Pharmacies & Providers
Changing Medicare plans
Special Enrollment Periods (SEPs)
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and high costs
Out-of-Pocket: TrOOP, RxMOOP, and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for higher incomes
Medicare Advantage plans (MAPD)
Medicare Supplements - Medigap
Medicare plan providers
General Medicare Part D (PDP)
General Medicare
Diabetes and diabetic coverage
Your Health & Wellness
About Q1Medicare.com


Ask a Pharmacist*
Have questions about your medication?

» Answers to Your Medication Questions, Free!
Available Monday - Friday
8am to 5pm MST
*A free service included with your no cost drug discount card.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.